These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24480931)

  • 21. Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.
    Felder CC; Goldsmith PJ; Jackson K; Sanger HE; Evans DA; Mogg AJ; Broad LM
    Neuropharmacology; 2018 Jul; 136(Pt C):449-458. PubMed ID: 29374561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia.
    Dean B; Scarr E
    Psychiatry Res; 2020 Jun; 288():112989. PubMed ID: 32315882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An allosteric enhancer of M₄ muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine.
    Dencker D; Weikop P; Sørensen G; Woldbye DP; Wörtwein G; Wess J; Fink-Jensen A
    Psychopharmacology (Berl); 2012 Nov; 224(2):277-87. PubMed ID: 22648127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching.
    McCool MF; Patel S; Talati R; Ragozzino ME
    Neurobiol Learn Mem; 2008 Feb; 89(2):114-24. PubMed ID: 17709264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptors.
    Šantrůčková E; Doležal V; El-Fakahany EE; Jakubík J
    PLoS One; 2014; 9(2):e88910. PubMed ID: 24558448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and Development of Muscarinic Acetylcholine M
    Takai K; Enomoto T
    Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats.
    Brady AE; Jones CK; Bridges TM; Kennedy JP; Thompson AD; Heiman JU; Breininger ML; Gentry PR; Yin H; Jadhav SB; Shirey JK; Conn PJ; Lindsley CW
    J Pharmacol Exp Ther; 2008 Dec; 327(3):941-53. PubMed ID: 18772318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
    Thal DM; Sun B; Feng D; Nawaratne V; Leach K; Felder CC; Bures MG; Evans DA; Weis WI; Bachhawat P; Kobilka TS; Sexton PM; Kobilka BK; Christopoulos A
    Nature; 2016 Mar; 531(7594):335-40. PubMed ID: 26958838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man.
    Ryberg AT; Warfvinge G; Axelsson L; Soukup O; Götrick B; Tobin G
    Arch Oral Biol; 2008 Jan; 53(1):66-74. PubMed ID: 17825245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.
    Woolley ML; Carter HJ; Gartlon JE; Watson JM; Dawson LA
    Eur J Pharmacol; 2009 Jan; 603(1-3):147-9. PubMed ID: 19111716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro.
    Savelkoul PJ; Janickova H; Kuipers AA; Hageman RJ; Kamphuis PJ; Dolezal V; Broersen LM
    J Neurochem; 2012 Feb; 120(4):631-40. PubMed ID: 22146060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscarinic receptor M
    Dall C; Weikop P; Dencker D; Molander AC; Wörtwein G; Conn PJ; Fink-Jensen A; Thomsen M
    Drug Alcohol Depend; 2017 Jul; 176():154-161. PubMed ID: 28544993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models.
    Digby GJ; Noetzel MJ; Bubser M; Utley TJ; Walker AG; Byun NE; Lebois EP; Xiang Z; Sheffler DJ; Cho HP; Davis AA; Nemirovsky NE; Mennenga SE; Camp BW; Bimonte-Nelson HA; Bode J; Italiano K; Morrison R; Daniels JS; Niswender CM; Olive MF; Lindsley CW; Jones CK; Conn PJ
    J Neurosci; 2012 Jun; 32(25):8532-44. PubMed ID: 22723693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Muscarinic M1 and/or M4 receptor agonists as potential novel treatments for psychoses].
    Spoelstra SK; Visser L; Knegtering H
    Tijdschr Psychiatr; 2023; 65(9):555-562. PubMed ID: 37947466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).
    Nawaratne V; Leach K; Suratman N; Loiacono RE; Felder CC; Armbruster BN; Roth BL; Sexton PM; Christopoulos A
    Mol Pharmacol; 2008 Oct; 74(4):1119-31. PubMed ID: 18628403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory.
    Wang Q; Wei X; Gao H; Li J; Liao J; Liu X; Qin B; Yu Y; Deng C; Tang B; Huang XF
    Neuroscience; 2014 May; 267():57-66. PubMed ID: 24613723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
    Birdsall NJ; Farries T; Gharagozloo P; Kobayashi S; Lazareno S; Sugimoto M
    Mol Pharmacol; 1999 Apr; 55(4):778-86. PubMed ID: 10101037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insular muscarinic signaling regulates anxiety-like behaviors in rats on the elevated plus-maze.
    Li H; Chen L; Li P; Wang X; Zhai H
    Behav Brain Res; 2014 Aug; 270():256-60. PubMed ID: 24844754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rat dorsal root ganglia express m1-m4 muscarinic receptor proteins.
    Bernardini N; Levey AI; Augusti-Tocco G
    J Peripher Nerv Syst; 1999; 4(3-4):222-32. PubMed ID: 10642090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.